PipeBio was founded by Owen Bodley, Jannick Bendtsen in 2020.

Who are PipeBio's investors?

PipeBio's investors include byFounders, Y Combinator, Acequia Capital (AceCap).

Where is PipeBio headquartered?

PipeBio is headquartered in Aarhus, DK.

PipeBio

AcquiredYC W21

Aarhus, DK · Founded 2020 · 10 employees · 3 known investors

Find your way into PipeBio

Paths you didn't know you had: your email and LinkedIn already hold routes to the PipeBio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

PipeBio provides a bioinformatics platform for drug discovery that enables scientists and bioinformaticians to analyze genomic and assay data. The platform combines sequence data management, machine learning tools, and visualization capabilities to accelerate therapeutic development for academia, biotech companies, and pharmaceutical firms.

Also known as Pipe|bio

AI & Machine Learning Biotech Cloud Computing Data & Infrastructure Healthtech SaaS AI-powered Drug Discovery Machine LearningDenmarkEuropeFully Remote

Founders & leadership· Y Combinator alumni (W21)

PipeBio was founded in 2020 by Owen Bodley and Jannick Bendtsen.

Owen Bodley PipeBio – CTO & Co-founder (Acquired by Benchling)2020–2025Owen Bodley has a background in mechanical engineering and has worked in software engineering for approximately seven years, focusing on bioinformatics and antibody drug discovery. He is a cofounder of PipeBio.

Jannick Bendtsen Co-founder | CEO2020–2024Jannick Bendtsen has spent over 15 years in commercial bioinformatics and holds expertise in molecular biology and bioinformatics, with experience in senior management roles.

Investors · 3

byFounderslisted by byFoundersCopenhagen · $540K – $4.3M

How we know: byFounders's portfolio page · open dataset · 5k.vc investor directory · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Acequia Capital (AceCap)reportedSeattle · $100K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 7

Diffuse BioDiffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.

Reverie LabsReverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.

OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.

CellChorusCellChorus develops a visual AI platform called TIMING that performs high-throughput dynamic analysis of single cells, measuring cell activation, killing, and movement over time for biopharmaceutical research. The company serves biopharmaceutical companies and therapy developers seeking to understand cellular function and phenotype.

ShiruShiru uses AI and material science to discover natural proteins and ingredients for use in food, personal care, agriculture, and advanced materials, reducing traditional development timelines from 5-15 years to 1-2 years.

Lavo Life SciencesLavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.

Twist BioscienceTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.

Companies working in the same space as PipeBio.

Legal entities · 1

corporate structure

PipeBio Inc.

Frequently asked questions

What does PipeBio do?: PipeBio provides a bioinformatics platform for drug discovery that enables scientists and bioinformaticians to analyze genomic and assay data. The platform combines sequence data management, machine learning tools, and visualization capabilities to accelerate therapeutic development for academia, biotech companies, and pharmaceutical firms.
Who founded PipeBio?: PipeBio was founded by Owen Bodley, Jannick Bendtsen in 2020.
Who are PipeBio's investors?: PipeBio's investors include byFounders, Y Combinator, Acequia Capital (AceCap).
Where is PipeBio headquartered?: PipeBio is headquartered in Aarhus, DK.